All employers have a duty of care to ensure a safe working environment. Alcohol and drug use and abuse along with fatigue all have the potential to impact on work safety, general health, job performance and working relationships. Most businesses have a designated alcohol and drug policy and strive to create a substance free work place. Drug and alcohol screening can involve urine, saliva or breathalyser testing. Urine screening is the most common method of testing, as it is considered the most accurate and efficient.
Instant Drug and Alcohol Screening
Instant drug and alcohol screening whether oral fluids or urine offers immediate results. All instant drug screening devices are self-contained and integrated units. The instant urine drug screening devices can be easily transported to pathology for confirmation analysis if required.
Instant drug screen devices do meet the Australian Standards AS/NZS 4308:2008. If a non-negative result is obtained from the screen the specimen is sent to a NATA accredited laboratory for confirmatory analysis.
Instant Drug and Alcohol Screening can also be provided at your workplace, whether metropolitan, regional or remote by our accredited drug screening staff.
Laboratory Based Screening
All laboratory based drug screens are performed to Australia Standard (AS/NZS 4308:2008). Complete Corporate Health collection protocols ensure prompt analysis and as short a turn- around of results as possible. Laboratories have the NATA accreditation and work closely with our Doctors to ensure clear communication to our Medical Review Officer ensuring the best care.
Drug and Alcohol Policy Review & Development
Drug and alcohol policy is the blueprint for a Company’s beliefs, tolerances and actions regarding drug use. Complete Corporate Health is able to provide expert assistance with development, review, guidance with drug and alcohol policies and procedures to ensure best practice.
Synthetic cannabinoids, as their name implies, are synthetically derived chemicals that are functionally similar to Δ9-tetrahydrocannabinol (THC), the active substance of cannabis. The synthetic cannabinoids are a group of chemicals that have slightly varied chemical make up but in general bind to the same cannabinoid receptors in the brain and other organs. Initially developed as therapeutic agents for the treatment of pain, they rapidly moved into the retail market for their THC-like effects while holding a quasi-legal position.
Synthetic cannabinoids were initially detected in Australia in late 2008. With evidence suggestive of increased use in Australian workplaces it was criminalized in 2011-12 throughout most Australian States and Territories.
With ready access via ordering on-line as well as ongoing development including changing the chemical make-up of these drugs, it remains a developing field for drug detection and surveillance.
Given the physiological and psychological effects including impaired motor coordination, reaction times and judgment, the safety implications are considerable concerning Workplace Health and Safety and General Duty of Care obligations throughout the workforce.